ZYXI - Zynex Soared Last Week. But Is It a Risky Buy?
Last week was a big one for Zynex (NASDAQ: ZYXI). The Colorado-based medical technology company specializes in manufacturing and selling noninvasive devices for pain management, stroke rehabilitation, neurological diagnostics, and cardiac monitoring.
Last Tuesday, it joined the S&P SmallCap 600 list. On Thursday, when everything else in the market seemed to be down, it rose to a 52-week high of $25.39. It slipped a little on Friday to $22.19, but is still up an incredible 182% for the year.
Yes, you read that last sentence correctly. Despite all the turmoil in the market this year, Zynex's share price has skyrocketed, with a 122% rise in the past three months alone. The question is: Can it continue?